Mwanzo068270 • KRX
add
Celltrion Inc
Bei iliyotangulia
₩ 160,500.00
Bei za siku
₩ 160,200.00 - ₩ 163,400.00
Bei za mwaka
₩ 150,400.00 - ₩ 200,952.39
Thamani ya kampuni katika soko
36.28T KRW
Wastani wa hisa zilizouzwa
elfu 460.25
Uwiano wa bei na mapato
61.82
Mgao wa faida
0.44%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 841.91B | 14.24% |
Matumizi ya uendeshaji wa biashara | 293.45B | 0.76% |
Mapato halisi | 108.67B | 384.28% |
Kiwango cha faida halisi | 12.91 | 324.67% |
Mapato kwa kila hisa | 529.00 | 414.31% |
EBITDA | 220.36B | 49.86% |
Asilimia ya kodi ya mapato | 44.58% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 970.72B | 5.45% |
Jumla ya mali | 20.96T | 4.00% |
Jumla ya dhima | 3.68T | 16.94% |
Jumla ya hisa | 17.28T | — |
hisa zilizosalia | 224.61M | — |
Uwiano wa bei na thamani | 2.10 | — |
Faida inayotokana na mali | 1.78% | — |
Faida inayotokana mtaji | 1.90% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 108.67B | 384.28% |
Pesa kutokana na shughuli | 113.45B | 206.45% |
Pesa kutokana na uwekezaji | -54.86B | -55.15% |
Pesa kutokana na ufadhili | -243.49B | -242.88% |
Mabadiliko halisi ya pesa taslimu | -167.36B | -191.58% |
Mtiririko huru wa pesa | 226.51B | 169.09% |
Kuhusu
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Tovuti
Wafanyakazi
2,391
